Rhythm Pharmaceuticals (RYTM) Cost of Revenue (2021 - 2026)
Rhythm Pharmaceuticals (RYTM) reported Cost of Revenue of $8.93 million for Q2 2026, up 61.1% from $5.54 million a year earlier and up 24.8% from the prior quarter.
Powered by 
Analysis
Rhythm Pharmaceuticals (RYTM) Cost of Revenue (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Rhythm Pharmaceuticals' Cost of Revenue came in at $26.39 million, up 57.0% year-over-year; for FY2025, it came in at $19.49 million, up 45.8% from FY2024.
- Cost of Revenue has increased for four consecutive years, with a four-year compound annual growth rate of 138.8% (FY2021 to FY2025).
- By year, Cost of Revenue came in at $13.37 million in FY2024 (+43.7%), $9.3 million in FY2023 (+336.1%), $2.13 million in FY2022 (+256.1%) and $599,000 in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Cost of Revenue in data going back to Q1 2021.
- Year over year, Cost of Revenue has now increased in each of the last 17 quarters, with growth averaging 52.7% over the last eight quarters.
- Across the past five years, year-over-year growth in Cost of Revenue ran from 17.1% in Q4 2024 to 517.8% in Q1 2023.
- Per Business Quant data, the three quarters before Q2 2026 came in at $7.16 million (Q1 2026), $4.8 million (Q4 2025) and $5.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Rhythm Pharmaceuticals | 6.39 Bn | 5.26 Bn | 62.32 Mn | 8.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.93 Mn |
| Mar 31, 2026 | 7.16 Mn |
| Dec 31, 2025 | 4.80 Mn |
| Sep 30, 2025 | 5.50 Mn |
| Jun 30, 2025 | 5.54 Mn |
| Mar 31, 2025 | 3.65 Mn |
| Dec 31, 2024 | 3.79 Mn |
| Sep 30, 2024 | 3.83 Mn |
| Jun 30, 2024 | 2.95 Mn |
| Mar 31, 2024 | 2.81 Mn |
| Dec 31, 2023 | 3.23 Mn |
| Sep 30, 2023 | 2.41 Mn |
| Jun 30, 2023 | 2.24 Mn |
| Mar 31, 2023 | 1.42 Mn |
| Dec 31, 2022 | 1.03 Mn |
| Sep 30, 2022 | 497,000.00 |
| Jun 30, 2022 | 378,000.00 |
| Mar 31, 2022 | 230,000.00 |
| Dec 31, 2021 | 236,000.00 |
| Sep 30, 2021 | 222,000.00 |
API Access
Rhythm Pharmaceuticals Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=RYTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "RYTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=RYTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();